Net income
-45 thousand USD
2023-10-01 – 2024-09-30
Fundies. English
SKINOVATION PHARMACEUTICAL INC
EDGAR99 filing records in this dataset, filed from 2000-11-07 to 2024-11-21. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 1.84 thousand USD Source
Exact value
1844 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 708 thousand shares Source
Exact value
708000 shares
Reported share-count change
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-16.3 thousand USD
2023-10-01 – 2024-09-30
Exact inputs and evidence
- Operating cash flow: -8929 USD · 2023-01-01 – 2023-12-31 Source
- Operating cash flow: -7029 USD · 2023-01-01 – 2023-09-30 Source
- Operating cash flow: -3500 USD · 2024-01-01 – 2024-03-31 Source
- Operating cash flow: -11000 USD · 2024-01-01 – 2024-06-30 Source
- Operating cash flow: -3500 USD · 2024-01-01 – 2024-03-31 Source
- Operating cash flow: -14390 USD · 2024-01-01 – 2024-09-30 Source
- Operating cash flow: -11000 USD · 2024-01-01 – 2024-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-11-21.
Financial data available through: 2023-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 11 of 11 periods available· newest 2023-12-31
- Net income: 11 of 11 periods available· newest 2023-12-31
- Operating cash flow: 11 of 11 periods available· newest 2023-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 11 of 11 periods available· newest 2023-12-31
- Total liabilities: 11 of 11 periods available· newest 2023-12-31
- Current assets: 11 of 11 periods available· newest 2023-12-31
- Current liabilities: 11 of 11 periods available· newest 2023-12-31
- Cash and cash equivalents: 11 of 11 periods available· newest 2023-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 11 of 11 periods available· newest 2023-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 2,123Prior period
−USD 33,743
–
Current period
−USD 35,866
–
Exact inputs and evidence
-35866 − -33743 = -2123 USD
-33743 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-35866 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 130Prior period
−USD 9,059
–
Current period
−USD 8,929
–
Exact inputs and evidence
-8929 − -9059 = 130 USD
-9059 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-8929 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2014 2014-01-01 – 2014-12-31 | −USD 26,946 Exact valueExact value: -26946 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6,940 Exact valueExact value: -6940 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2015 2015-01-01 – 2015-12-31 | −USD 26,930 Exact valueExact value: -26930 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7,100 Exact valueExact value: -7100 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2016-01-01 – 2016-12-31 | −USD 27,442 Exact valueExact value: -27442 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7,625 Exact valueExact value: -7625 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | −USD 27,415 Exact valueExact value: -27415 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6,730 Exact valueExact value: -6730 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | −USD 28,588 Exact valueExact value: -28588 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5,715 Exact valueExact value: -5715 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 29,727 Exact valueExact value: -29727 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7,455 Exact valueExact value: -7455 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 30,957 Exact valueExact value: -30957 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8,725 Exact valueExact value: -8725 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 32,450 Exact valueExact value: -32450 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6,830 Exact valueExact value: -6830 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 33,743 Exact valueExact value: -33743 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9,059 Exact valueExact value: -9059 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 35,866 Exact valueExact value: -35866 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 8,929 Exact valueExact value: -8929 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
99 filings · 2,115 latest values · 2,115 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001118072, 1118072, edgar:1118072
Also known as SKINOVATION PHARMACEUTICAL INC, SKINOVATION PHARMACEUTICAL INC., SKINOVATION PHARMACEUTICAL INCORPORATED